Literature DB >> 7884804

Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China.

M Tanaka1, Y X Zhang, H Ishida, T Akasaka, K Sato, I Hayakawa.   

Abstract

Ninety-two and 33 methicillin-resistant Staphylococcus aureus (MRSA) strains were isolated in Japan and China respectively. They were categorised as ofloxacin-susceptible (MIC < 12.5 mg/L), moderately (MIC 12.5-25 mg/L) or highly (MIC > or = 50 mg/L) ofloxacin-resistant. 4-Quinolone concentrations required to inhibit purified DNA gyrase from the moderately and highly quinolone-resistant MRSA were at least 20 times higher than those required to inhibit the equivalent enzyme from quinolone-susceptible strains. Reconstitution assays demonstrated that the 4-quinolone-resistant MRSA had a mutation in subunit A of DNA gyrase. A portion of the gyrA gene from amino acids codons 40-115 was sequenced. Four moderately resistant and seven highly resistant MRSA contained a Ser-->Leu substitution at amino acid 84; one moderately and one highly resistant MRSA and one moderately resistant methicillin-susceptible S. aureus (MSSA) strain contained a Glu-->Lys substitution at amino acid 88. Eight MRSA, including one quinolone-susceptible strain and one MSSA contained a silent mutation at amino acid 86. Uptake of ofloxacin in moderately resistant strains was almost the same in the presence or absence of carbonyl cyanide m-chlorophenylhydrazone (CCCP), whereas in highly resistant strains, uptake increased when CCCP was added. Restriction fragment length analysis of the norA gene with the restriction endonuclease SfcI showed a mutation of nucleotide position 1085 in all MRSA strains tested except for one highly quinolone-resistant strain. Thus the mechanisms of 4-quinolone-resistance in these MRSA isolates involved alterations in both DNA gyrase and antimicrobial uptake and efflux.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7884804     DOI: 10.1099/00222615-42-3-214

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  14 in total

Review 1.  Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  Use of a three-dimensional microarray system for detection of levofloxacin resistance and the mec A gene in Staphylococcus aureus.

Authors:  Tomonori Nagaoka; Toshinobu Horii; Takatomo Satoh; Tomoko Ito; Akio Monji; Akihiro Takeshita; Masato Maekawa
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Detection of grlA and gyrA mutations in 344 Staphylococcus aureus strains.

Authors:  T Wang; M Tanaka; K Sato
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

4.  In vitro activity of HSR-903, a new quinolone.

Authors:  Y Takahashi; N Masuda; M Otsuki; M Miki; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

5.  Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus.

Authors:  M Tanaka; Y Onodera; Y Uchida; K Sato; I Hayakawa
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

6.  Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin.

Authors:  C Bisognano; P E Vaudaux; D P Lew; E Y Ng; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 7.  Mechanisms of fluoroquinolone resistance: an update 1994-1998.

Authors:  L J Piddock
Journal:  Drugs       Date:  1999       Impact factor: 9.546

8.  Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin.

Authors:  C Bisognano; P Vaudaux; P Rohner; D P Lew; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

9.  Quinolone resistance mutations in the GrlB protein of Staphylococcus aureus.

Authors:  M Tanaka; Y Onodera; Y Uchida; K Sato
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

10.  Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis.

Authors:  J M Entenza; O Marchetti; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.